In Vitro and In Vivo Diagnostic Substances - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the In industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

In Vitro and In Vivo Diagnostic Substances - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - In Vitro and In Vivo Diagnostic Substances
Corporate Insider Buy Sell Ratio (Insider Count) - In Vitro and In Vivo Diagnostic Substances
In Vitro and In Vivo Diagnostic Substances - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE M - Exercise D 56
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE M - Exercise D 204
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 MAZELSKY JAY M - Exercise D 1,099
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata M - Exercise D 1,508
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE M - Exercise D 139
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 MAZELSKY JAY M - Exercise D 958
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Lane Michael M - Exercise D 367
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Lane Michael M - Exercise D 301
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Schreck Michael M - Exercise D 1,005
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Schreck Michael M - Exercise D 367
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Erickson Michael G M - Exercise D 94
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Erickson Michael G M - Exercise D 92
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata M - Exercise D 301
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Lane Michael M - Exercise D 204
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Lane Michael M - Exercise D 220
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Schreck Michael M - Exercise D 301
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Erickson Michael G M - Exercise D 184
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Underberg Sharon E. M - Exercise D 176
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Emerson Andrew M - Exercise D 194
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Emerson Andrew M - Exercise D 94
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Underberg Sharon E. M - Exercise D 218
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Emerson Andrew M - Exercise D 42
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Emerson Andrew M - Exercise D 61
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Emerson Andrew M - Exercise D 65
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Underberg Sharon E. M - Exercise D 265
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Underberg Sharon E. M - Exercise D 173
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Johnson Michael Perkins M - Exercise D 179
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Johnson Michael Perkins M - Exercise D 176
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Johnson Michael Perkins M - Exercise D 218
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Smith Martin Alexander M - Exercise D 148
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Smith Martin Alexander M - Exercise D 367
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Smith Martin Alexander M - Exercise D 301
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Smith Martin Alexander M - Exercise D 188
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Smith Martin Alexander F - Taxes D 629.35 -302
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Johnson Michael Perkins F - Taxes D 629.35 -178
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Erickson Michael G F - Taxes D 629.35 -974
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE F - Taxes D 629.35 -199
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Lane Michael F - Taxes D 629.35 -221
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Schreck Michael F - Taxes D 629.35 -876
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 MAZELSKY JAY F - Taxes D 629.35 -915
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata F - Taxes D 629.35 -1,154
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Underberg Sharon E. F - Taxes D 629.35 -251
2026-02-14 IDXX / IDEXX Laboratories, Inc. 4 Emerson Andrew F - Taxes D 629.35 -123
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE S - Sale D 648.7792 -966
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE S - Sale D 645.2512 -2,161
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE S - Sale D 644.016 -397
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE S - Sale D 646.2259 -2,782
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE S - Sale D 642.9974 -1,130
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE S - Sale D 647.2066 -1,060
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE S - Sale D 650.32 -40
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)